Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-3364
Full Text
Open PDFAbstract
Available in full text
Date
June 8, 2015
Authors
Publisher
American Association for Cancer Research (AACR)